Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Has results × Gelatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostate Cancer Prevention 1

Interventions

Cyclophosphamide 760 Carboplatin 662 Paclitaxel 617 Bevacizumab 601 pembrolizumab 583 Cisplatin 574 Gemcitabine 517 Docetaxel 481 Radiotherapy 463 Rituximab 459 Dexamethasone 418 Nivolumab 386 Doxorubicin 374 Fluorouracil 326 Capecitabine 326 Etoposide 303 Pemetrexed 280 Cytarabine 279 Oxaliplatin 278 Lenalidomide 272 Prednisone 271 fludarabine phosphate 262 Erlotinib Hydrochloride 254 Leucovorin 253 fludarabine 250 Trastuzumab 244 Bortezomib 240 Vincristine 238 Filgrastim 233 Cetuximab 226

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01265953 2019-05-01

PBroC

Portland VA Medical Center

Phase NA Completed

98 enrolled 10 charts

Prostate Cancer Prevention

Data powered by HemOnc (CC BY 4.0) Colophon ⚡